Alembic Pharmaceuticals gets EIR from USFDA for API - I, API - II facility at Panelav

15 Sep 2025 Evaluate

Alembic Pharmaceuticals has received an Establishment Inspection Report (EIR) for the inspection carried out by US Food and Drug Administration (USFDA) at the company's API - I & API - II facility located at Panelav. The inspection was conducted from May 26, 2025 to May 31, 2025.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.

Alembic Pharma Share Price

771.90 -4.35 (-0.56%)
19-Feb-2026 10:15 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1722.95
Dr. Reddys Lab 1285.00
Cipla 1352.50
Zydus Lifesciences 912.55
Lupin 2221.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×